Stem Cell Agency Evaluation Subcommittee Meeting October 7, 2010

Oct 7, 2010
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
8170 Laguna Blvd., #215 Elk Grove, CA 95758
Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville, CA 94608
The Sherry Lansing Foundation 2121 Avenue of the Stars, Suite 2020 Los Angeles, CA 90067
Klein Financial Corporation 550 California Avenue, Suite 330 Palo Alto, CA 94306
Alta Partners One Embarcadero Center 37th Floor San Francisco, CA 94111
San Francisco City Attorney's Office San Francisco International Airport International Terminal, 5th Floor San Francisco, CA 94128
9060 Friars Road San Diego, CA 92108

 

Stem Cell Agency Evaluation Subcommittee Meeting
 

 
MEETING NOTICE AND AGENDA
 
REGULAR TELECONFERENCE MEETING
EVALUATION SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
 
Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
 
 
Open Session
 
1.  Call to Order.
 
2.  Roll Call.
 
3. Public Comment
 
Closed Session
 
4. Discussion of Personnel [Evaluation of President] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).
 
Return to Open Session
 
5. Adjournment.
 
**NOTICE**
 
The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
 
Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.
 
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov 

 

© 2013 California Institute for Regenerative Medicine